
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: Protocol for a three-arm, single-blind randomized controlled trial (the Flow-CRRT Study) - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5329878AF194C3052987006A193F59.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373228/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: Protocol for a three-arm, single-blind randomized controlled trial (the Flow-CRRT Study)">
<meta name="citation_author" content="Caihong Liu">
<meta name="citation_author_institution" content="Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China">
<meta name="citation_author" content="Qiongxing Bu">
<meta name="citation_author_institution" content="Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China">
<meta name="citation_author" content="Fang Wang">
<meta name="citation_author_institution" content="Department of Nephrology, West China Hospital of Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China">
<meta name="citation_author" content="Wei Wei">
<meta name="citation_author_institution" content="Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China">
<meta name="citation_author" content="Yongxiu Huang">
<meta name="citation_author_institution" content="Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China">
<meta name="citation_author" content="Jinglei Ren">
<meta name="citation_author_institution" content="Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China">
<meta name="citation_author" content="Jay L Koyner">
<meta name="citation_author_institution" content="Department of Medicine, University of Chicago, Chicago, United States of America">
<meta name="citation_author" content="Ling Zhang">
<meta name="citation_author_institution" content="Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China">
<meta name="citation_author" content="Yuliang Zhao">
<meta name="citation_author_institution" content="Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0330845">
<meta name="citation_doi" content="10.1371/journal.pone.0330845">
<meta name="citation_pmid" content="40845006">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373228/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373228/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373228/pdf/pone.0330845.pdf">
<meta name="description" content="Non-anticoagulation is a commonly used strategy in continuous renal replacement therapy (CRRT) among patients with high-bleeding risk. However, the optimal blood flow rate (BFR) to maximize filter and circuit life remains uncertain. This study is ...">
<meta name="og:title" content="Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: Protocol for a three-arm, single-blind randomized controlled trial (the Flow-CRRT Study)">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Non-anticoagulation is a commonly used strategy in continuous renal replacement therapy (CRRT) among patients with high-bleeding risk. However, the optimal blood flow rate (BFR) to maximize filter and circuit life remains uncertain. This study is ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373228/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12373228">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0330845"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0330845.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373228%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12373228/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12373228/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373228/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0330845" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 22;20(8):e0330845. doi: <a href="https://doi.org/10.1371/journal.pone.0330845" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330845</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: Protocol for a three-arm, single-blind randomized controlled trial (the Flow-CRRT Study)</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Caihong Liu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Caihong Liu</span></h3>
<div class="p">
<sup>1</sup>Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China</div>
<div>Conceptualization, Formal analysis, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Caihong Liu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bu%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Qiongxing Bu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Qiongxing Bu</span></h3>
<div class="p">
<sup>1</sup>Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China</div>
<div>Data curation, Methodology</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bu%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qiongxing Bu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Fang Wang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Fang Wang</span></h3>
<div class="p">
<sup>2</sup>Department of Nephrology, West China Hospital of Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fang Wang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wei%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Wei Wei</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Wei Wei</span></h3>
<div class="p">
<sup>1</sup>Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China</div>
<div>Methodology</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wei%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wei Wei</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Yongxiu Huang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Yongxiu Huang</span></h3>
<div class="p">
<sup>1</sup>Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yongxiu Huang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ren%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Jinglei Ren</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Jinglei Ren</span></h3>
<div class="p">
<sup>1</sup>Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China</div>
<div>Methodology</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ren%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jinglei Ren</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Koyner%20JL%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Jay L Koyner</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Jay L Koyner</span></h3>
<div class="p">
<sup>3</sup>Department of Medicine, University of Chicago, Chicago, United States of America</div>
<div>Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Koyner%20JL%22%5BAuthor%5D" class="usa-link"><span class="name western">Jay L Koyner</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Ling Zhang</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Ling Zhang</span></h3>
<div class="p">
<sup>1</sup>Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China</div>
<div>Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Ling Zhang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yuliang Zhao</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yuliang Zhao</span></h3>
<div class="p">
<sup>1</sup>Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China</div>
<div>Conceptualization, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuliang Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Wisit Kaewput,</span><sup>4</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China</div>
<div id="aff002">
<sup>2</sup>Department of Nephrology, West China Hospital of Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China</div>
<div id="aff003">
<sup>3</sup>Department of Medicine, University of Chicago, Chicago, United States of America</div>
<div id="edit1">
<sup>4</sup>Phramongkutklao College of Medicine, THAILAND</div>
<div class="author-notes p">
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>zhaoyuliang@scu.edu.cn</span></p>
</div>
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors declare that they have no competing interests.</p></div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Caihong Liu</span></strong>: <span class="role">Conceptualization, Formal analysis, Writing – original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Qiongxing Bu</span></strong>: <span class="role">Data curation, Methodology</span>
</div>
<div>
<strong class="contrib"><span class="name western">Fang Wang</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Wei Wei</span></strong>: <span class="role">Methodology</span>
</div>
<div>
<strong class="contrib"><span class="name western">Yongxiu Huang</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jinglei Ren</span></strong>: <span class="role">Methodology</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jay L Koyner</span></strong>: <span class="role">Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Ling Zhang</span></strong>: <span class="role">Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Yuliang Zhao</span></strong>: <span class="role">Conceptualization, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Wisit Kaewput,</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 1; Accepted 2025 Aug 5; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Liu et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12373228  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40845006/" class="usa-link">40845006</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec001"><h3 class="pmc_sec_title">Background</h3>
<p>Non-anticoagulation is a commonly used strategy in continuous renal replacement therapy (CRRT) among patients with high-bleeding risk. However, the optimal blood flow rate (BFR) to maximize filter and circuit life remains uncertain. This study is designed to elucidate the impact of different BFRs on the durability of filters and circuits in CRRT without anticoagulation.</p></section><section id="sec002"><h3 class="pmc_sec_title">Methods</h3>
<p>This single-center, prospective, three-arm, single-blind, randomized controlled trial (RCT) will involve adult patients requiring non-anticoagulation continuous veno-venous hemodiafiltration (CVVHDF). A total of 486 filters and circuits will be enrolled and randomly assigned to one of three BFR groups: low (150 mL/min), medium (200 mL/min), or high (250 mL/min) BFR group. The outcomes will be analyzed by both intention-to-treat analysis and per-protocol analysis. The primary outcome is filter and circuit life, which is defined as the time from CRRT initiation to CRRT termination due to extracorporeal circuit clotting or other reasons, alongside the proportion of patent circuits at 24, 48, and 72 hours. Secondary outcomes encompass clinical outcomes and potential adverse events such as bleeding and hemodynamic alterations.</p></section><section id="sec003"><h3 class="pmc_sec_title">Discussion</h3>
<p>This study is aiming at comparing the filter and circuit life under different BFR levels during CVVHDF without anti-coagulation. The results may add knowledge to the optimal BFR to prevent extracorporeal circulation clotting and prolong filter and circuit life in non-anticoagulation CRRT.</p></section><section id="sec004"><h3 class="pmc_sec_title">Trial registration</h3>
<p>The study has been registered at <a href="https://www.chictr.org.cn" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.chictr.org.cn</a> (ChiCTR2400087819).</p></section></section><section id="sec005"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Continuous renal replacement therapy (CRRT) is a pivotal blood purification technique, renowned for its role in eliminating excess water, toxins, inflammatory factors, and autoantibodies from the circulation. It has become increasingly used in the management of a spectrum of critical conditions such as acute kidney injury (AKI) and sepsis [<a href="#pone.0330845.ref001" class="usa-link" aria-describedby="pone.0330845.ref001">1</a>]. The successful performance of CRRT is contingent upon the unobstructed extracorporeal circulation, thus maintaining it for at least 24 hours. Clotting of the filter and circuit can prematurely terminate therapy, diminishing treatment efficacy, and increasing the risk of blood loss, healthcare workload, and economic burden [<a href="#pone.0330845.ref002" class="usa-link" aria-describedby="pone.0330845.ref002">2</a>–<a href="#pone.0330845.ref004" class="usa-link" aria-describedby="pone.0330845.ref004">4</a>]. For decades, studies have focused on optimized anticoagulation strategies to extend the life of extracorporeal devices, such as heparin and regional citrate anticoagulation (RCA) [<a href="#pone.0330845.ref005" class="usa-link" aria-describedby="pone.0330845.ref005">5</a>,<a href="#pone.0330845.ref006" class="usa-link" aria-describedby="pone.0330845.ref006">6</a>]. Nevertheless, coagulation-free CRRT is inevitable, especially in patients with high bleeding and those with contraindications of available anti-coagulants [<a href="#pone.0330845.ref007" class="usa-link" aria-describedby="pone.0330845.ref007">7</a>]. A large multinational study reported that non-anticoagulation CRRT accounted for 24% of all CRRT treatments [<a href="#pone.0330845.ref008" class="usa-link" aria-describedby="pone.0330845.ref008">8</a>]. However, it is reported that filter and circuit life was significantly shorter for the non-anticoagulation strategy in comparison with RCA-CRRT (14.3 vs. 44.9 hours, <em>P</em> &lt; 0.001), though no significant disparity in CRRT efficacy has been observed [<a href="#pone.0330845.ref009" class="usa-link" aria-describedby="pone.0330845.ref009">9</a>].</p>
<p>Beyond anticoagulants, non-pharmacological interventions to prolong filter and circuit life, including the choice of therapy modalities, blood flow rates (BFR), catheter sites and types have been investigated [<a href="#pone.0330845.ref010" class="usa-link" aria-describedby="pone.0330845.ref010">10</a>]. Evidence showed that continuous veno-venous hemodialysis (CVVHD) and continuous veno-venous hemodiafiltration (CVVHDF) might prolong filter lifespan compared with continuous veno-venous hemofiltration (CVVH) [<a href="#pone.0330845.ref011" class="usa-link" aria-describedby="pone.0330845.ref011">11</a>,<a href="#pone.0330845.ref012" class="usa-link" aria-describedby="pone.0330845.ref012">12</a>], while no difference was observed between CVVHD and CVVHDF groups [<a href="#pone.0330845.ref013" class="usa-link" aria-describedby="pone.0330845.ref013">13</a>]. BFR is a key, easily adjustable parameter in CRRT, and clinical practice varies widely, with BFRs ranging from 80 to over 300 mL/min globally [<a href="#pone.0330845.ref014" class="usa-link" aria-describedby="pone.0330845.ref014">14</a>,<a href="#pone.0330845.ref015" class="usa-link" aria-describedby="pone.0330845.ref015">15</a>]. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines suggest that BFRs between 150–250 mL/min are typically prescribed for CRRT modalities such as CVVH and CVVHDF, but offer no evidence-based recommendations for optimal values [<a href="#pone.0330845.ref016" class="usa-link" aria-describedby="pone.0330845.ref016">16</a>]. While BFRs &gt; 200 mL/min have been empirically recommended to maintain circuit patency [<a href="#pone.0330845.ref017" class="usa-link" aria-describedby="pone.0330845.ref017">17</a>], more recent studies have suggested that very high BFRs (e.g., &gt; 250 mL/min) may actually shorten circuit life, possibly due to increased circuit pressure [<a href="#pone.0330845.ref013" class="usa-link" aria-describedby="pone.0330845.ref013">13</a>,<a href="#pone.0330845.ref018" class="usa-link" aria-describedby="pone.0330845.ref018">18</a>]. A randomized controlled trial (RCT) comparing BFRs of 150 and 250 mL/min in CRRT found no significant difference in circuit clotting risk, irrespective of anticoagulation strategy [<a href="#pone.0330845.ref019" class="usa-link" aria-describedby="pone.0330845.ref019">19</a>]. Given the relatively low quality, substantial heterogeneity, and controversial findings among previous studies, there is insufficient evidence to draw a solid conclusion on optimal BFR in non-anticoagulation CRRT. Moreover, while clinicians often choose among standard BFR settings (150, 200, or 250 mL/min), no study to date has systematically compared circuit lifespan across these three levels in non-anticoagulated CRRT. In this parallel-group, single-blind, three-arm RCT, we aimed to compare the impacts of different BFRs (150mL/min vs. 200mL/min vs. 250mL/min) on circuit life and other secondary outcomes in patients receiving non-anticoagulation CRRT. This study aims to inform practice where no evidence currently guides BFR selection.</p></section><section id="sec006"><h2 class="pmc_sec_title">2. Methods and analysis</h2>
<section id="sec007"><h3 class="pmc_sec_title">2.1. Ethics and dissemination</h3>
<p>The study is conducted in compliance with the Declaration of Helsinki and has received ethical approval from the Institutional Review Board of West China Hospital (Approval No: 2024—918). It has been registered at <a href="https://www.chictr.org.cn" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.chictr.org.cn</a> (ChiCTR2400087819) on 5 August 2024. It is important to note that neither participants nor the public will be involved in the study’s design, conduct, or dissemination. We will publish the results of our research in medical journals after the study. The study data will be available upon request, ensuring transparency and accessibility. The enrollment of patients is scheduled to commence at a university-affiliated medical center in September 2024. This study is ongoing now. The participant recruitment will be completed in March 2025. Throughout the trial, trained clinical staff will closely monitor adverse events, including hypotension, arrhythmias, bleeding, and other potential complications. If one group exhibits a significantly higher incidence of serious adverse events related to treatment (non-anticoagulation CRRT or BFR setting), such as hypotension, malignant arrhythmia, or death, compared to the other two groups, or if the incidence exceeds predefined safety thresholds, termination of the intervention for that group will be considered immediately. Additionally, an independent Data Safety Monitoring Committee (DSMC) will regularly review trial data to ensure patient safety.</p></section><section id="sec008"><h3 class="pmc_sec_title">2.2. Study design</h3>
<p>This will be a monocenter, prospective, parallel-group, single-blind, three-arm RCT designed to evaluate the impact of BFRs on filter and circuit life during anticoagulation-free CRRT. After obtaining informed consent, 486 sets of filters and circuits will be consecutively recruited and randomized to low BFR (150 mL/min) group, medium BFR (200 mL/min) group, or high BFR (250 mL/min) group. Given that a single patient may contribute multiple filters and circuits, each filter or circuit is treated as a distinct unit for randomization within the study. The allocation concealment will be maintained such that the participants are blinded to the treatment assignment: (1) Allocation Concealment: The CRRT machines and settings will be managed exclusively by the trained CRRT staff, who will not disclose BFR assignments to patients or their families. (2) Visual Blinding: The BFR setting on the CRRT machine screen will be obscured or made non-interpretable to patients to prevent inadvertent unblinding. The clinical teams are not masked as the BFR is shown on the machine. Adhering to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Statement, we have outlined the trial design and protocol in detail (<a href="#pone.0330845.g001" class="usa-link">Fig 1</a>).</p>
<figure class="fig xbox font-sm" id="pone.0330845.g001"><h4 class="obj_head">Fig 1. Schedule of enrollment, interventions, and assessments according to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guideline.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373228_pone.0330845.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ef/12373228/78c70aee8166/pone.0330845.g001.jpg" loading="lazy" height="372" width="771" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330845.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec009"><h3 class="pmc_sec_title">2.3. Study objectives</h3>
<p>The principal objective of this RCT is to ascertain the impact of varied BFRs on the longevity of filters and circuits in the context of anticoagulation-free CRRT, including the filter and circuit life and the proportion of patent circuits living up to 24 hours, 48 hours, and 72 hours. The secondary objectives encompass the comparisons regarding the blood pressure changes, extracorporeal circulation pressure, patients’ in-hospital mortality, hospital and ICU duration, invasive mechanical ventilation and dialysis-dependency rate, and the incidence of adverse events like bleeding.</p></section><section id="sec010"><h3 class="pmc_sec_title">2.4. Study participants</h3>
<p>Adult patients who require CRRT at a university-affiliated medical center are screened as potential participants in this RCT. The inclusion criteria are as follows: a) aged over 18 years; b) scheduled to receive non-coagulation CRRT; and c) provision of informed consent by the patient or their legally authorized representative. Patients are excluded for the following reasons: a) received systemic anti-coagulation for indications other than CRRT (for example ECMO); b) unable to perform CRRT according to the pre-set BFR due to hemodynamic instability, vascular access dysfunction (CRRT machine alarm and blood pump shutdown occurs due to poor catheter function) or other reasons; c) pregnant women. Nephrologists specialized in CRRT will be responsible for screening when patients are considered requiring CRRT without coagulation by a joint team of nephrologist and ICU physician. All the eligible patients or his/her proxy will be thoroughly informed clearly of the objective, procedure, expected benefits, and possible risks of participating in this study. Both the patient and the treating physician are required to sign the informed consent form, signifying their mutual understanding and agreement. Confidentiality of all patient information will be maintained, and patients have the right to withdraw from the study at any time without incurring any penalties or prejudice.</p></section><section id="sec011"><h3 class="pmc_sec_title">2.5. Randomization</h3>
<p>The random number sequences are generated with Python by an independent statistician, ensuring the utmost impartiality and integrity. Upon confirmation of eligibility, participants will be randomly allocated in a 1:1:1 ratio to one of the three study groups: low, middle, or high BFR. The respective BFRs for these groups during non-anticoagulation CRRT will be set at 150 mL/min, 200 mL/min, and 250 mL/min. The allocation results will be monitored by an independent coordinator and blinded to the patients.</p></section><section id="sec012"><h3 class="pmc_sec_title">2.6. Intervention</h3>
<p>All the patients involved in this study will receive non-anticoagulation CVVHDF in post-dilution mode. The CRRT machine and catheter type, therapeutic dosage, filtration rate, and vascular access are not pre-specified and may vary according to clinical standards and patient-specific requirements. The BFR for extracorporeal circulation will be standardized into three levels across participants. It is stipulated that the BFR may be adjusted downward in a stepwise manner only in instances where the circuit experiences excessive pressure or triggers pressure alarms due to vascular access insufficiency. However, if the team decides that a lower BFR is not acceptable, the catheter will be adjusted or reimplanted to guarantee the predefined target. In instances where a patient discontinues extracorporeal circulation due to unplanned disruptions like examination/therapy trips, transference to other departments/hospitals during CRRT, the duration of filter/circuit utilization shall be meticulously documented.</p></section><section id="sec013"><h3 class="pmc_sec_title">2.7. Outcome measures</h3>
<p>The primary outcome is filter and circuit life, defined as the time interval from the initiation to the termination of a single CRRT session for any reasons as well as for non-electively ceased filter and circuit due to clotting. We will also compare the proportions of extracorporeal circulation achieving 24-hour, 48-hour, and 72-hour lifespans, with specific attention to the filters and circuits suspension owing to coagulation.</p>
<p>The secondary outcomes include 1) patients’ clinical outcomes: in-hospital mortality, length of hospital/ICU stay, and invasive mechanical ventilation and dialysis-dependency rate; 2) hemodynamic parameters such as blood pressure changes during CRRT; 3) adverse events like bleeding.</p></section><section id="sec014"><h3 class="pmc_sec_title">2.8. Sample size calculations</h3>
<p>According to our retrospective analysis enrolling CRRT patients with non-coagulants in West China Hospital of Sichuan University, the median filter and circuit life of no-anticoagulation CRRT within our unit was 28.09 ± 21.15 hours for a BFR of 200 mL/min, whereas 34.17 ± 16.36 hours for a BFR of 250 mL/min. By employing Power analysis and sample size software (version 11.0, PASS, NCSS LCC, Kaysville, UT, USA), we calculated the sample size with a two-sided type I error of 0.05 and 90% power. One hundred and fifty-three extracorporeal circuits, will be needed in each group. Accounting for a dropout rate of 5% where the patient/proxy withdraw inform consent or the physician considers the patient unsuitable to continue the study, a total of 486 filters or circuits are to be included in this RCT.</p></section><section id="sec015"><h3 class="pmc_sec_title">2.9. Statistical analysis</h3>
<p>Personal information (e.g., name, telephone number) will be kept confidential. Statistics will be presented as the means ± standard deviations (SDs) or medians with interquartile ranges (IQRs) for continuous variables and percentages for categorical variables. For missing data, the multiple imputation method will be used as appropriate, which allows for a more robust and statistically valid approach by incorporating uncertainty. Differences between the two groups will be measured by t test for continuous variables with a normal distribution, the Mann–Whitney U test for variables with a nonnormal distribution, and the χ2 test or Fisher’s exact test for categorical variables.</p>
<p>Time to filter or circuit coagulation will be compared between groups by the use of Kaplan-Meier curves and log-rank tests. Univariable analysis will be conducted to evaluate the impact of potential confounding factors (such as age, body mass index, laboratory parameters, and filtration fraction) on the filter and circuit survival. Then multivariable Cox regression model will be adjusted to estimate the independent risk factors. The results will be expressed as hazard ratio (HR) and 95% confidential interval (95% CI). We will use the Schoenfeld residual test to verify the assumption of proportional hazards in the Cox analysis. In cases of non-proportionality, stratified Cox models or incorporating time-varying effects will be considered as appropriate. In addition, logistic regression will be conducted to identify the potential risk factors for the incidence of pre-mature extracorporeal circulation coagulation, which will be presented by odds ratio (OR) and 95% CI. Subgroup analyses will be conducted to separately evaluate the effects of BFR on filter lifespan and circuit lifespan, as well as based on the type of filter used. Of note, the sample size might limit the ability to control for numerous covariates, even with randomization. Therefore, we will prioritize the independently protective or risk factors identified by a retrospective cohort study we previously conducted, including filter type, substitute fluid rate, patients’ coagulation function, hematocrit level, and whether exposure to non-CRRT anti-coagulation agents or concomitant with hyperlipidemia to control for. Although if it is balanced as expected, we will conduct a sensitivity analysis to examine the robustness of our primary findings.</p>
<p>Given that patients may receive multiple CRRT sessions, resulting in clustered data, we will use a mixed-effects model to account for within-patient correlation, treating individual filters as the unit of analysis and patients as random effects. A random intercept model will capture different baseline risks of filter failure across patients. The primary fixed effect will be BFRs, with patient-level covariates such as age, baseline coagulation function, and renal function included to assess their independent associations with filter and circuit life. However, current data may not provide sufficient power to reliably estimate all variance components in the proposed complex random-effects structure. To address this methodological challenge while maintaining scientific rigor, we will implement a stepwise modeling approach: Initially, we will attempt to fit the pre-specified maximal model incorporating all planned random effects. Should we encounter convergence issues or observe unstable variance estimates (operationally defined as standard errors exceeding the mean estimate), we will systematically simplify the model by first removing random slopes for less critical covariates while preserving random intercepts for key clustering variables like study sites. Throughout this process, we will conduct comprehensive sensitivity analyses to evaluate the impact of model simplifications on both model fit statistics (AIC/BIC) and the stability of fixed-effects estimates, with particular attention to our primary exposure variables. All model adaptations, along with their justifications and validation results, will be thoroughly documented in the supplementary materials to ensure full transparency. Poisson regression will be used to model the count data for coagulation frequency, assuming that the mean and variance are equal. If the variance substantially exceeds the mean, a phenomenon known as overdispersion, negative binomial regression may be considered, since it allows for greater flexibility by incorporating a dispersion parameter. In both models, patient ID will be a random effect to account for repeated measures, and rate ratio (RR) with 95% CI will be estimated for the impact of covariates on filter and circuit survival.</p>
<p>Both intention-to-treat (ITT) analysis and per-protocol (PP) analysis will be performed. For ITT analysis, once enrolled in the study, all data will be analyzed according to the group randomly assigned, regardless of possible protocol violations (e.g., changes in anticoagulation modality or BFR). For PP analysis, only CRRT sessions that finished the treatment as planned will be included in the analyses. All the statistical analyses were performed via R software (version 4.3; R Foundation for Statistical Computing, Vienna, Austria). A <em>P</em> value of &lt; 0.05 will be considered to indicate statistical significance.</p></section></section><section id="sec016"><h2 class="pmc_sec_title">Discussion</h2>
<p>The FLOW-CRRT study is a prospective, three-arm RCT designed to investigate the hypothesis that higher BFR can prolong the lifespan of extracorporeal circulation in CRRT without anticoagulation.</p>
<p>While anticoagulants are routinely used to extend filter and circuit life in CRRT, certain clinical situations, such as high bleeding risk or altered coagulation function, warrant the exploration of non-pharmacological strategies to improve circuit patency when non-anticoagulation CRRT is indicated. Common non-pharmacologic measures to prolong filter and circuit life include selection of appropriate treatment modality (CVVHD, CVVHDF), mode of dilution, type of filter, management of effluent volume and filtration fraction (&lt;25–30%) [<a href="#pone.0330845.ref020" class="usa-link" aria-describedby="pone.0330845.ref020">20</a>–<a href="#pone.0330845.ref022" class="usa-link" aria-describedby="pone.0330845.ref022">22</a>], however these parameters are usually determined by clinical need and institutional experience. Besides, patient’s underlying disease, patient comorbidity, intravenous infusion of blood production and nutrients solution are also potential influential factors to filter and circuit longevity in CRRT.</p>
<p>Extracorporeal circulation BFR is a flexible parameter which could be easily adjusted during CRRT. Though recommendations for higher BFR have been proposed to address the short lifespan in clinical practice, there is no conclusive evidence from large-scale RCT studies, and the optimal BFR in CRRT without anticoagulant has yet to be established [<a href="#pone.0330845.ref013" class="usa-link" aria-describedby="pone.0330845.ref013">13</a>]. From a physiological standpoint, higher BFR is hypothesized to reduce clot formation by shortening the contact time between extracorporeal blood and filters and circuits and minimizing platelet adhesion and activation, as well as coagulation cascade. However, over-highly BFR could exacerbate hemodynamic instability in critically ill patients, posing challenge to filtration efficacy and patient safety [<a href="#pone.0330845.ref023" class="usa-link" aria-describedby="pone.0330845.ref023">23</a>]. Therefore, determination of the optimal BFR could be related with improved filter and circuit longevity, while its impact on CRRT therapeutic effect and patient adverse events should also be closely monitored.</p>
<p>Literature have reported short filter and circuit lifespans in non-anticoagulation CRRT using low BFR. Zhang <em>et al.</em> observed the filter lifespan in anticoagulant-free CRRT at a BFR of 200 mL/min, reporting an overall filter lifespan of 20.5 hours and 16 hours for coagulated filters. The accumulated filter survival probabilities at 12-hour, 24-hour, and 48-hour were 80%, 47%, and 7%, respectively [<a href="#pone.0330845.ref024" class="usa-link" aria-describedby="pone.0330845.ref024">24</a>]. In another study by Ratanarat. et al. analyzing non-anticoagulation CRRT in critically ill AKI patients with the BFR at 150–200 mL/min, they found that the rate of circuit exchanges due to filter clotting was as high as 71.1% and the median circuit life was only 14.3 hours [<a href="#pone.0330845.ref009" class="usa-link" aria-describedby="pone.0330845.ref009">9</a>]. According to a single-center, retrospective, observational study where 355 patients and 1332 CRRT treatments were assessed for filter life, higher BFR was related with increased CRRT filter lifespan [<a href="#pone.0330845.ref025" class="usa-link" aria-describedby="pone.0330845.ref025">25</a>]. However, in an RCT involving 96 AKI patients, a BFR of 150 mL/min was not more likely to cause clotting compared with 250 mL/min [<a href="#pone.0330845.ref019" class="usa-link" aria-describedby="pone.0330845.ref019">19</a>]. Given the discrepancy of previous studies and the lack of study dedicated to non-anticoagulation CRRT, the FLOW-CRRT trial seeks to advance knowledge by comparing three BFR levels (150, 200, and 250 mL/min), a range chosen based on current clinical practice, on filter and circuit life and other secondary outcomes in patients receiving non-anticoagulation CRRT. The primary aim is to determine whether higher BFRs can mitigate clotting and extend circuit longevity, providing a clinically feasible non-pharmacological strategy where systemic or regional anti-coagulation is contraindicated. It may also help establish evidence-based recommendations on BFR in anticoagulant-free CRRT settings to reduce clotting-related complications and even patient outcomes. Both PP and ITT analyses will be performed. In real-world clinical settings, deviations such as initiating anticoagulation or modifying the BFR during a single CRRT session may occur. Theoretically, whatever anticoagulation modality shifts from anticoagulation-free will aid the prolongation of circuit lifespan. However, such events are expected to occur at a similar rate across the randomized groups.</p>
<p>There are several inherent limitations to this trial that must be acknowledged. First, as a single-center study, the findings may be limited by the lack of regional and ethnic diversity, potentially constraining the generalizability of our findings. A multi-center approach involving population across different countries and regions is essential to validate the findings and applicability. Second, maintaining strict adherence to predefined BFRs may prove challenging in practice due to vascular access dysfunction and hemodynamic instability. Deviations from the intended BFR allocation could impact the accuracy and robustness of the results. Third, this study does not include an economic analysis of CRRT costs associated with extracorporeal circuit clotting, which is an important consideration for healthcare systems. Addressing these gaps will be a priority for subsequent research.</p>
<p>In summary, this study is a prospective RCT exploring the influence of BFR on the extracorporeal circuit life in CRRT without anti-coagulation. By identifying the optimal BFR, the findings might help reduce the frequency of filter and circuit clotting, minimize patient risk, lower healthcare costs, and contribute to the development of evidence-based CRRT protocols for high bleeding risk patients. The findings will also be inspiring for future multi-center studies exploring optimized BFR strategies of CRRT.</p></section><section id="sec017"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0330845.s001"><div class="caption p">
<span>S1 File. SPIRI checklist.</span><p>(DOC)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373228/bin/pone.0330845.s001.doc" data-ga-action="click_feat_suppl" class="usa-link">pone.0330845.s001.doc</a><sup> (121KB, doc) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330845.s002"><div class="caption p">
<span>S2 File. Study protocol in Chinese.</span><p>(DOC)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373228/bin/pone.0330845.s002.doc" data-ga-action="click_feat_suppl" class="usa-link">pone.0330845.s002.doc</a><sup> (147KB, doc) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330845.s003"><div class="caption p">
<span>S3 File. Study protocol in English.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373228/bin/pone.0330845.s003.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330845.s003.docx</a><sup> (35KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>None.</p></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author(s) received no specific funding for this work.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0330845.ref001">
<span class="label">1.</span><cite>de Pont AC, Oudemans-van Straaten HM, Roozendaal KJ, Zandstra DF. Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study. Crit Care Med. 2000;28(2):421–5. doi: 10.1097/00003246-200002000-00022

</cite> [<a href="https://doi.org/10.1097/00003246-200002000-00022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10708177/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care%20Med&amp;title=Nadroparin%20versus%20dalteparin%20anticoagulation%20in%20high-volume,%20continuous%20venovenous%20hemofiltration:%20a%20double-blind,%20randomized,%20crossover%20study&amp;author=AC%20de%20Pont&amp;author=HM%20Oudemans-van%20Straaten&amp;author=KJ%20Roozendaal&amp;author=DF%20Zandstra&amp;volume=28&amp;issue=2&amp;publication_year=2000&amp;pages=421-5&amp;pmid=10708177&amp;doi=10.1097/00003246-200002000-00022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref002">
<span class="label">2.</span><cite>Webb AR, Mythen MG, Jacobson D, Mackie IJ. Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation. Intensive Care Med. 1995;21(1):84–93. doi: 10.1007/BF02425162

</cite> [<a href="https://doi.org/10.1007/BF02425162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7560483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Intensive%20Care%20Med&amp;title=Maintaining%20blood%20flow%20in%20the%20extracorporeal%20circuit:%20haemostasis%20and%20anticoagulation&amp;author=AR%20Webb&amp;author=MG%20Mythen&amp;author=D%20Jacobson&amp;author=IJ%20Mackie&amp;volume=21&amp;issue=1&amp;publication_year=1995&amp;pages=84-93&amp;pmid=7560483&amp;doi=10.1007/BF02425162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref003">
<span class="label">3.</span><cite>Joannidis M, Oudemans-van Straaten HM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care. 2007;11(4):218. doi: 10.1186/cc5937

</cite> [<a href="https://doi.org/10.1186/cc5937" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2206533/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17634148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care&amp;title=Clinical%20review:%20Patency%20of%20the%20circuit%20in%20continuous%20renal%20replacement%20therapy&amp;author=M%20Joannidis&amp;author=HM%20Oudemans-van%20Straaten&amp;volume=11&amp;issue=4&amp;publication_year=2007&amp;pages=218&amp;pmid=17634148&amp;doi=10.1186/cc5937&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref004">
<span class="label">4.</span><cite>Tsujimoto H, Tsujimoto Y, Nakata Y, Fujii T, Takahashi S, Akazawa M, et al. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy. Cochrane Database Syst Rev. 2020;12(12):CD012467. doi: 10.1002/14651858.CD012467.pub3

</cite> [<a href="https://doi.org/10.1002/14651858.CD012467.pub3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8812343/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33314078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20Syst%20Rev&amp;title=Pharmacological%20interventions%20for%20preventing%20clotting%20of%20extracorporeal%20circuits%20during%20continuous%20renal%20replacement%20therapy&amp;author=H%20Tsujimoto&amp;author=Y%20Tsujimoto&amp;author=Y%20Nakata&amp;author=T%20Fujii&amp;author=S%20Takahashi&amp;volume=12&amp;issue=12&amp;publication_year=2020&amp;pmid=33314078&amp;doi=10.1002/14651858.CD012467.pub3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref005">
<span class="label">5.</span><cite>Wu M-Y, Hsu Y-H, Bai C-H, Lin Y-F, Wu C-H, Tam K-W. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012;59(6):810–8. doi: 10.1053/j.ajkd.2011.11.030

</cite> [<a href="https://doi.org/10.1053/j.ajkd.2011.11.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22226564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Regional%20citrate%20versus%20heparin%20anticoagulation%20for%20continuous%20renal%20replacement%20therapy:%20a%20meta-analysis%20of%20randomized%20controlled%20trials&amp;author=M-Y%20Wu&amp;author=Y-H%20Hsu&amp;author=C-H%20Bai&amp;author=Y-F%20Lin&amp;author=C-H%20Wu&amp;volume=59&amp;issue=6&amp;publication_year=2012&amp;pages=810-8&amp;pmid=22226564&amp;doi=10.1053/j.ajkd.2011.11.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref006">
<span class="label">6.</span><cite>Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?
Crit Care. 2011;15(1):202. doi: 10.1186/cc9358

</cite> [<a href="https://doi.org/10.1186/cc9358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3222015/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21345279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care&amp;title=Clinical%20review:%20anticoagulation%20for%20continuous%20renal%20replacement%20therapy--heparin%20or%20citrate?&amp;author=HM%20Oudemans-van%20Straaten&amp;author=JA%20Kellum&amp;author=R%20Bellomo&amp;volume=15&amp;issue=1&amp;publication_year=2011&amp;pages=202&amp;pmid=21345279&amp;doi=10.1186/cc9358&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref007">
<span class="label">7.</span><cite>Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding. J Nephrol. 2003;16(4):566–71. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/14696760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Nephrol&amp;title=Continuous%20renal%20replacement%20therapies:%20anticoagulation%20in%20the%20critically%20ill%20at%20high%20risk%20of%20bleeding&amp;author=S%20Morabito&amp;author=I%20Guzzo&amp;author=A%20Solazzo&amp;author=L%20Muzi&amp;author=R%20Luciani&amp;volume=16&amp;issue=4&amp;publication_year=2003&amp;pages=566-71&amp;pmid=14696760&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref008">
<span class="label">8.</span><cite>STARRT-AKI Investigators, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group, United Kingdom Critical Care Research Group, Canadian Nephrology Trials Network, Irish Critical Care Trials Group, et al. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med. 2020;383(3):240–51. doi: 10.1056/NEJMoa2000741

</cite> [<a href="https://doi.org/10.1056/NEJMoa2000741" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32668114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Timing%20of%20Initiation%20of%20Renal-Replacement%20Therapy%20in%20Acute%20Kidney%20Injury&amp;volume=383&amp;issue=3&amp;publication_year=2020&amp;pages=240-51&amp;pmid=32668114&amp;doi=10.1056/NEJMoa2000741&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref009">
<span class="label">9.</span><cite>Ratanarat R, Phairatwet P, Khansompop S, Naorungroj T. Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial. Blood Purif. 2023;52(5):455–63. doi: 10.1159/000529076

</cite> [<a href="https://doi.org/10.1159/000529076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10332480/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36858026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood%20Purif&amp;title=Customized%20Citrate%20Anticoagulation%20versus%20No%20Anticoagulant%20in%20Continuous%20Venovenous%20Hemofiltration%20in%20Critically%20Ill%20Patients%20with%20Acute%20Kidney%20Injury:%20A%20Prospective%20Randomized%20Controlled%20Trial&amp;author=R%20Ratanarat&amp;author=P%20Phairatwet&amp;author=S%20Khansompop&amp;author=T%20Naorungroj&amp;volume=52&amp;issue=5&amp;publication_year=2023&amp;pages=455-63&amp;pmid=36858026&amp;doi=10.1159/000529076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref010">
<span class="label">10.</span><cite>Tsujimoto Y, Fujii T. How to Prolong Filter Life During Continuous Renal Replacement Therapy?
Crit Care. 2022;26(1):62. doi: 10.1186/s13054-022-03910-8

</cite> [<a href="https://doi.org/10.1186/s13054-022-03910-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8957143/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35337352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care&amp;title=How%20to%20Prolong%20Filter%20Life%20During%20Continuous%20Renal%20Replacement%20Therapy?&amp;author=Y%20Tsujimoto&amp;author=T%20Fujii&amp;volume=26&amp;issue=1&amp;publication_year=2022&amp;pages=62&amp;pmid=35337352&amp;doi=10.1186/s13054-022-03910-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref011">
<span class="label">11.</span><cite>Ricci Z, Ronco C, Bachetoni A, D’amico G, Rossi S, Alessandri E, et al. Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion. Crit Care. 2006;10(2):R67. doi: 10.1186/cc4903

</cite> [<a href="https://doi.org/10.1186/cc4903" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1550874/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16646985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care&amp;title=Solute%20removal%20during%20continuous%20renal%20replacement%20therapy%20in%20critically%20ill%20patients:%20convection%20versus%20diffusion&amp;author=Z%20Ricci&amp;author=C%20Ronco&amp;author=A%20Bachetoni&amp;author=G%20D%E2%80%99amico&amp;author=S%20Rossi&amp;volume=10&amp;issue=2&amp;publication_year=2006&amp;pmid=16646985&amp;doi=10.1186/cc4903&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref012">
<span class="label">12.</span><cite>Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int. 2006;70(7):1312–7. doi: 10.1038/sj.ki.5001705

</cite> [<a href="https://doi.org/10.1038/sj.ki.5001705" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16850022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Adding%20a%20dialysis%20dose%20to%20continuous%20hemofiltration%20increases%20survival%20in%20patients%20with%20acute%20renal%20failure&amp;author=P%20Saudan&amp;author=M%20Niederberger&amp;author=S%20De%20Seigneux&amp;author=J%20Romand&amp;author=J%20Pugin&amp;volume=70&amp;issue=7&amp;publication_year=2006&amp;pages=1312-7&amp;pmid=16850022&amp;doi=10.1038/sj.ki.5001705&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref013">
<span class="label">13.</span><cite>Sansom B, Sriram S, Presneill J, Bellomo R. Low Blood Flow Continuous Veno-Venous Haemodialysis Compared with Higher Blood Flow Continuous Veno-Venous Haemodiafiltration: Effect on Alarm Rates, Filter Life, and Azotaemic Control. Blood Purif. 2022;51(2):130–7. doi: 10.1159/000516146

</cite> [<a href="https://doi.org/10.1159/000516146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34010832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood%20Purif&amp;title=Low%20Blood%20Flow%20Continuous%20Veno-Venous%20Haemodialysis%20Compared%20with%20Higher%20Blood%20Flow%20Continuous%20Veno-Venous%20Haemodiafiltration:%20Effect%20on%20Alarm%20Rates,%20Filter%20Life,%20and%20Azotaemic%20Control&amp;author=B%20Sansom&amp;author=S%20Sriram&amp;author=J%20Presneill&amp;author=R%20Bellomo&amp;volume=51&amp;issue=2&amp;publication_year=2022&amp;pages=130-7&amp;pmid=34010832&amp;doi=10.1159/000516146&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref014">
<span class="label">14.</span><cite>Fealy N, Aitken L, du Toit E, Baldwin I. Continuous renal replacement therapy: current practice in Australian and New Zealand intensive care units. Crit Care Resusc. 2015;17(2):83–91. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/26017125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care%20Resusc&amp;title=Continuous%20renal%20replacement%20therapy:%20current%20practice%20in%20Australian%20and%20New%20Zealand%20intensive%20care%20units&amp;author=N%20Fealy&amp;author=L%20Aitken&amp;author=E%20du%20Toit&amp;author=I%20Baldwin&amp;volume=17&amp;issue=2&amp;publication_year=2015&amp;pages=83-91&amp;pmid=26017125&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref015">
<span class="label">15.</span><cite>Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007;33(9):1563–70. doi: 10.1007/s00134-007-0754-4

</cite> [<a href="https://doi.org/10.1007/s00134-007-0754-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17594074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Intensive%20Care%20Med&amp;title=Continuous%20renal%20replacement%20therapy:%20a%20worldwide%20practice%20survey.%20The%20beginning%20and%20ending%20supportive%20therapy%20for%20the%20kidney%20(B.E.S.T.%20kidney)%20investigators&amp;author=S%20Uchino&amp;author=R%20Bellomo&amp;author=H%20Morimatsu&amp;author=S%20Morgera&amp;author=M%20Schetz&amp;volume=33&amp;issue=9&amp;publication_year=2007&amp;pages=1563-70&amp;pmid=17594074&amp;doi=10.1007/s00134-007-0754-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref016">
<span class="label">16.</span><cite>KDIGO Clinical Practice Guidelines for Acute Kidney Injury | Nephron Clinical Practice | Karger Publishers. [cited 12 Jul 2025]. Available from: <a href="https://karger.com/nec/article-abstract/120/4/c179/830716/KDIGO-Clinical-Practice-Guidelines-for-Acute?redirectedFrom=fulltext" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://karger.com/nec/article-abstract/120/4/c179/830716/KDIGO-Clinical-Practice-Guidelines-for-Acute?redirectedFrom=fulltext</a></cite>
</li>
<li id="pone.0330845.ref017">
<span class="label">17.</span><cite>Ronco C, Ricci Z, De Backer D, Kellum JA, Taccone FS, Joannidis M, et al. Renal replacement therapy in acute kidney injury: controversy and consensus. Crit Care. 2015;19(1):146. doi: 10.1186/s13054-015-0850-8

</cite> [<a href="https://doi.org/10.1186/s13054-015-0850-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4386097/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25887923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care&amp;title=Renal%20replacement%20therapy%20in%20acute%20kidney%20injury:%20controversy%20and%20consensus&amp;author=C%20Ronco&amp;author=Z%20Ricci&amp;author=D%20De%20Backer&amp;author=JA%20Kellum&amp;author=FS%20Taccone&amp;volume=19&amp;issue=1&amp;publication_year=2015&amp;pages=146&amp;pmid=25887923&amp;doi=10.1186/s13054-015-0850-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref018">
<span class="label">18.</span><cite>Tsujimoto Y, Miki S, Shimada H, Tsujimoto H, Yasuda H, Kataoka Y, et al. Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy. Cochrane Database Syst Rev. 2021;9(9):CD013330. doi: 10.1002/14651858.CD013330.pub2

</cite> [<a href="https://doi.org/10.1002/14651858.CD013330.pub2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8438600/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34519356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20Syst%20Rev&amp;title=Non-pharmacological%20interventions%20for%20preventing%20clotting%20of%20extracorporeal%20circuits%20during%20continuous%20renal%20replacement%20therapy&amp;author=Y%20Tsujimoto&amp;author=S%20Miki&amp;author=H%20Shimada&amp;author=H%20Tsujimoto&amp;author=H%20Yasuda&amp;volume=9&amp;issue=9&amp;publication_year=2021&amp;pmid=34519356&amp;doi=10.1002/14651858.CD013330.pub2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref019">
<span class="label">19.</span><cite>Fealy N, Aitken L, du Toit E, Lo S, Baldwin I. Faster Blood Flow Rate Does Not Improve Circuit Life in Continuous Renal Replacement Therapy: A Randomized Controlled Trial. Crit Care Med. 2017;45(10):e1018–25. doi: 10.1097/CCM.0000000000002568

</cite> [<a href="https://doi.org/10.1097/CCM.0000000000002568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28658026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care%20Med&amp;title=Faster%20Blood%20Flow%20Rate%20Does%20Not%20Improve%20Circuit%20Life%20in%20Continuous%20Renal%20Replacement%20Therapy:%20A%20Randomized%20Controlled%20Trial&amp;author=N%20Fealy&amp;author=L%20Aitken&amp;author=E%20du%20Toit&amp;author=S%20Lo&amp;author=I%20Baldwin&amp;volume=45&amp;issue=10&amp;publication_year=2017&amp;pmid=28658026&amp;doi=10.1097/CCM.0000000000002568&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref020">
<span class="label">20.</span><cite>Hu C, Shui P, Zhang B, Xu X, Wang Z, Wang B, et al. How to safeguard the continuous renal replacement therapy circuit: a narrative review. Front Med (Lausanne). 2024;11:1442065. doi: 10.3389/fmed.2024.1442065

</cite> [<a href="https://doi.org/10.3389/fmed.2024.1442065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11373359/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39234046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Med%20(Lausanne)&amp;title=How%20to%20safeguard%20the%20continuous%20renal%20replacement%20therapy%20circuit:%20a%20narrative%20review&amp;author=C%20Hu&amp;author=P%20Shui&amp;author=B%20Zhang&amp;author=X%20Xu&amp;author=Z%20Wang&amp;volume=11&amp;publication_year=2024&amp;pages=1442065&amp;pmid=39234046&amp;doi=10.3389/fmed.2024.1442065&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref021">
<span class="label">21.</span><cite>del Castillo J, López-Herce J, Cidoncha E, Urbano J, Mencía S, Santiago MJ, et al. Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Crit Care. 2008;12(4):R93. doi: 10.1186/cc6965

</cite> [<a href="https://doi.org/10.1186/cc6965" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2575577/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18657277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care&amp;title=Circuit%20life%20span%20in%20critically%20ill%20children%20on%20continuous%20renal%20replacement%20treatment:%20a%20prospective%20observational%20evaluation%20study&amp;author=J%20del%20Castillo&amp;author=J%20L%C3%B3pez-Herce&amp;author=E%20Cidoncha&amp;author=J%20Urbano&amp;author=S%20Menc%C3%ADa&amp;volume=12&amp;issue=4&amp;publication_year=2008&amp;pmid=18657277&amp;doi=10.1186/cc6965&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref022">
<span class="label">22.</span><cite>Davies HT, Leslie G, Pereira SM, Webb SAR. A randomized comparative crossover study to assess the affect on circuit life of varying pre-dilution volume associated with CVVH and CVVHDF. Int J Artif Organs. 2008;31(3):221–7. doi: 10.1177/039139880803100305

</cite> [<a href="https://doi.org/10.1177/039139880803100305" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18373315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Artif%20Organs&amp;title=A%20randomized%20comparative%20crossover%20study%20to%20assess%20the%20affect%20on%20circuit%20life%20of%20varying%20pre-dilution%20volume%20associated%20with%20CVVH%20and%20CVVHDF&amp;author=HT%20Davies&amp;author=G%20Leslie&amp;author=SM%20Pereira&amp;author=SAR%20Webb&amp;volume=31&amp;issue=3&amp;publication_year=2008&amp;pages=221-7&amp;pmid=18373315&amp;doi=10.1177/039139880803100305&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref023">
<span class="label">23.</span><cite>Ronco C, Bellomo R. Continuous renal replacement therapy: evolution in technology and current nomenclature. Kidney Int Suppl. 1998;66:S160-4. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9573595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int%20Suppl&amp;title=Continuous%20renal%20replacement%20therapy:%20evolution%20in%20technology%20and%20current%20nomenclature&amp;author=C%20Ronco&amp;author=R%20Bellomo&amp;volume=66&amp;publication_year=1998&amp;pmid=9573595&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref024">
<span class="label">24.</span><cite>Zhang W, Bai M, Zhang L, Yu Y, Li Y, Zhao L, et al. Development and External Validation of a Model for Predicting Sufficient Filter Lifespan in Anticoagulation-Free Continuous Renal Replacement Therapy Patients. Blood Purif. 2022;51(8):668–78. doi: 10.1159/000519409

</cite> [<a href="https://doi.org/10.1159/000519409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9501746/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34673634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood%20Purif&amp;title=Development%20and%20External%20Validation%20of%20a%20Model%20for%20Predicting%20Sufficient%20Filter%20Lifespan%20in%20Anticoagulation-Free%20Continuous%20Renal%20Replacement%20Therapy%20Patients&amp;author=W%20Zhang&amp;author=M%20Bai&amp;author=L%20Zhang&amp;author=Y%20Yu&amp;author=Y%20Li&amp;volume=51&amp;issue=8&amp;publication_year=2022&amp;pages=668-78&amp;pmid=34673634&amp;doi=10.1159/000519409&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330845.ref025">
<span class="label">25.</span><cite>Dunn WJ, Sriram S. Filter lifespan in critically ill adults receiving continuous renal replacement therapy: the effect of patient and treatment-related variables. Crit Care Resusc. 2014;16(3):225–31. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/25161027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Care%20Resusc&amp;title=Filter%20lifespan%20in%20critically%20ill%20adults%20receiving%20continuous%20renal%20replacement%20therapy:%20the%20effect%20of%20patient%20and%20treatment-related%20variables&amp;author=WJ%20Dunn&amp;author=S%20Sriram&amp;volume=16&amp;issue=3&amp;publication_year=2014&amp;pages=225-31&amp;pmid=25161027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="pone.0330845.r001"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0330845.r001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330845.r001</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 0</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaewput%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Wisit Kaewput</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Wisit Kaewput</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaewput%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wisit Kaewput</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Wisit Kaewput</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.c" class="d-panel p" style="display: none">
<div>© 2025 Wisit Kaewput</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>25 Jun 2025</em>
</p>
<p>PONE-D-25-01201Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: protocol for a three-arm, single-blind randomized controlled trial (the Flow-CRRT Study)PLOS ONE</p>
<p>Dear Dr. Zhao,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Please submit your revised manuscript by Aug 09 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <span>plosone@plos.org</span> . When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:</p>
<ul class="list" style="list-style-type:disc">
<li><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></li>
<li><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></li>
<li><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></li>
</ul>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a> . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</a> .</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Wisit Kaewput, MD</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>When submitting your revision, we need you to address these additional requirements.</p>
<p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
<p><a href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</a> and</p>
<p>
<a href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</a>
</p>
<p>2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.</p>
<p>3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.</p>
<p>When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.</p>
<p>4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.</p>
<p>5. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.</p>
<p>6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <a href="http://journals.plos.org/plosone/s/supporting-information" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://journals.plos.org/plosone/s/supporting-information</a>.</p>
<p>7. Please remove all personal information, ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set.</p>
<p>Note: spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file.</p>
<p>Additional guidance on preparing raw data for publication can be found in our Data Policy (<a href="https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data</a>) and in the following article: <a href="http://www.bmj.com/content/340/bmj.c181.long" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.bmj.com/content/340/bmj.c181.long</a> .</p>
<p>8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?</p>
<p>The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>Reviewer #4: Yes</p>
<p>Reviewer #5: Yes</p>
<p>**********</p>
<p>2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?</p>
<p>The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>Reviewer #4: Yes</p>
<p>Reviewer #5: Yes</p>
<p>**********</p>
<p>3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?</p>
<p>Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>Reviewer #4: Yes</p>
<p>Reviewer #5: Yes</p>
<p>**********</p>
<p>4. Have the authors described where all data underlying the findings will be made available when the study is complete?</p>
<p>The <a href="https://journals.plos.org/plosone/s/materials-and-software-sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>Reviewer #4: No</p>
<p>Reviewer #5: Yes</p>
<p>**********</p>
<p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: Yes</p>
<p>Reviewer #4: Yes</p>
<p>Reviewer #5: Yes</p>
<p>**********</p>
<p>6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.</p>
<p>You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.</p>
<p>(Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #1: As the statisitcal reviewer I will focus on methods and reporting. The trial is generally well design and the approaches are clear. the power calculations are appropriate.</p>
<p>1) mean imputation is not ideal, why wasn't multiple imputation considered instead? and this can be relevant to all modelling choices.</p>
<p>2) univariable and multivariable analyses, not univariate and multivariate</p>
<p>3) make sure you assess the proportional hazards assumption for the Cox models</p>
<p>4) number may be low for controlling for numerous covariates (especially if many are categorical) so the authors need to be ready to prioritise what to control for, if that is the case. Although if there is enough balance in all aspects through the randomisation (as expected since numbers are large for a trial, relatively) a univariable approach would be adequate, at least as a sensitivity analysis.</p>
<p>5) the random effects models are appropriate and well through, but the numbers may be small to safely estimate all components, so again the authors may have to compromise.</p>
<p>Reviewer #2: This is a study proposal. The factors under study are very relevant . The study once completed will give good insight into the problem we routinely encounter</p>
<p>A multicenter study will definitely be better</p>
<p>Reviewer #3: Clarify the impact of protocol deviations, such as BFR adjustments due to clinical needs, on both ITT and PP analyses by providing more information. It would be helpful for clinicians to clarify this.</p>
<p>Despite the thorough statistical approach, certain terminology (such as use of Poisson instead of negative binomial models) may require a succinct explanation for those unfamiliar with count data and overdispersion.</p>
<p>Despite being written in the usual English language, minor modifications could enhance readability (for instance, “staying patent for 24 hours” could be modified to “maintaining it for at least 24 hours”).</p>
<p>Overall, this protocol is technically sound and will provide good data that can inform clinical practice.</p>
<p>Reviewer #4: A randomized controlled trial (RCT) protocol on effects of different blood flow rates on filter life and circuit patency in non-anticoagulation CRRT. this RCT protocol is written in detail and supplementary information file and SPIRIT checklist is complete. I think this protocol satisfies PLOS One publication criteria and is suitable for publication.</p>
<p>I recommend that authors include more information about patients’ safety in the manuscript as they have included in the SI file of trial study protocol.</p>
<p>As per PLOS One Submission Guidelines “the name of the registry and the trial or study registration number must be included in the Abstract”. Moreover, the authors have not described where all data underlying the findings will be made available when the study is complete</p>
<p>Reviewer #5: In their study protocol titled “Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: protocol for a three-arm, single-blind randomized controlled trial (the FlowCRRT Study),” Liu et al. present an important and timely research question. However, I recommend the following revisions to further strengthen the manuscript.</p>
<p>1. Page 8, Introduction Section: The introduction fails to clearly explain the reasoning behind the chosen blood flow rate (BFR) thresholds of 150, 200, and 250 mL/min. As a result, readers may struggle to grasp their clinical significance or the supporting evidence. Including a brief justification based on guidelines or common practice would strengthen the study’s foundation.</p>
<p>2. Page 8, Introduction Section: The authors mention conflicting evidence regarding optimal blood flow rates, with some studies recommending BFR &gt;200 mL/min and others suggesting lower rates may improve circuit patency. However, this important issue is not sufficiently discussed. The introduction would benefit from a clearer synthesis of these differing viewpoints and a more explicit acknowledgment of the ongoing debate in the literature. Highlighting this discrepancy would better justify the need for the current study.</p>
<p>3. Page 9, Study design: The authors should clearly specify how participants will be blinded to treatment assignment in the study design section. While they mention that allocation concealment will be maintained, the exact method of blinding is not described and should be explicitly stated to ensure transparency and reproducibility.</p>
<p>4. Page 9, Study objectives: The authors should avoid vague phrasing and explicitly list the specific secondary outcomes that will be evaluated. Terms like "patient clinical outcomes" and "hemodynamic parameter changes" are too broad, clearly defining which parameters will be assessed is important for the authors to communicate the outcomes effectively.</p>
<p>5. Page 9, Study Participants: The manuscript lacks detail on the screening process for eligible patients. The authors should specify who will be responsible for screening (e.g., nephrologist, ICU physician) and when this will occur during patient care to ensure a clear understanding of the recruitment procedure.</p>
<p>6. Page 9: The authors redundantly mention the blood flow rate (BFR) values in both the Randomization and Intervention sections. This redundancy can be eliminated by presenting the information a single time and making references to it later.</p>
<p>**********</p>
<p>7. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a> .</p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: <strong>Yes: </strong> Dr. Archith Boloor</p>
<p>Reviewer #3: <strong>Yes: </strong> Malak Mohmmed Saed Abdulqadir ( Alagoury )</p>
<p>Reviewer #4: No</p>
<p>Reviewer #5: No</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <a href="https://pacev2.apexcovantage.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pacev2.apexcovantage.com/</a> . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <span>figures@plos.org</span> . Please note that Supporting Information files do not need this step.</p></section></article><article class="sub-article" id="pone.0330845.r002"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. 2025 Aug 22;20(8):e0330845. doi: <a href="https://doi.org/10.1371/journal.pone.0330845.r002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330845.r002</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response to Decision Letter 1</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.d" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.d" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.d" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub2" class="history"><p>Collection date 2025.</p></section></div></div>
<div id="clp_a.d" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>21 Jul 2025</em>
</p>
<p>Dear Editors and Reviewers:</p>
<p>Thank you for your consideration and for the reviewer’s comments concerning our manuscript entitled “Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: protocol for a three-arm, single-blind randomized controlled trial (the Flow-CRRT Study)” (Manuscript ID: PONE-D-25-01201). The comments were valuable and helpful for revising and improving our manuscript. We have studied the comments carefully with great gratitude and have made corrections and improvements. The detailed point-by-point responses to the reviewer’s comments are as follows. The revised portions are highlighted in RED in the revised manuscript.</p>
<p>I hope that the revised manuscript is suitable for publication in Plos One. I am truly grateful for your help with the manuscript.</p>
<p>Reviewer:</p>
<p>Reviewer #1: As the statistical reviewer I will focus on methods and reporting. The trial is generally well design and the approaches are clear. the power calculations are appropriate.</p>
<p>Comment 1</p>
<p>mean imputation is not ideal, why wasn't multiple imputation considered instead? and this can be relevant to all modelling choices.</p>
<p>Authors’ response: Thanks for the helpful comment. We agree that mean imputation is limited and may lead to biased estimates and underestimation of variance. As you suggested, multiple imputation allows for a more robust and statistically valid approach by incorporating uncertainty arising from missing data. In response, multiple imputation will be used instead of mean imputation to better address this methodological concern. (Page 5, Line 208-210)</p>
<p>Comment 2</p>
<p>univariable and multivariable analyses, not univariate and multivariate.</p>
<p>Authors’ response: Thank you for your kind reminder. We have rectified “univariate” to “univariable” and “multivariate” to “multivariable”. (Page 5, Line 215, 218)</p>
<p>Comment 3</p>
<p>make sure you assess the proportional hazards assumption for the Cox models</p>
<p>Authors’ response: Sincerely appreciate for bringing the proportional hazards assumption to our attention for the Cox models. We will use the Schoenfeld residual test to verify the assumption of proportional hazards in the Cox analysis. In cases of non-proportionality, stratified Cox models or incorporating time-dependent effects will be considered as appropriate. We have added the assessment approach in the revised paper. (Page 5-6, Line 220-222)</p>
<p>Comment 4</p>
<p>number may be low for controlling for numerous covariates (especially if many are categorical) so the authors need to be ready to prioritise what to control for, if that is the case. Although if there is enough balance in all aspects through the randomisation (as expected since numbers are large for a trial, relatively) a univariable approach would be adequate, at least as a sensitivity analysis.</p>
<p>Authors’ response: Thanks for your thoughtful advice. While randomization is expected to ensure baseline balance, the sample size might limit the ability to control for numerous covariates. Therefore, we will prioritize the independently protective or risk factors identified by a retrospective cohort study we previously conducted, including filter type, substitute fluid rate, patients’ coagulation function, hematocrit level, and whether exposure to non-CRRT anti-coagulation agents or concomitant with hyperlipidemia. Then, clinically relevant covariates such as age, gender, and serum creatinine will also be seriously considered if necessary (The retrospective cohort study has not been published yet; we would be pleased to provide the results if needed). Although if it is balanced as expected, we will also conduct a sensitivity analysis with univariable models to examine the robustness of our primary findings. Thanks again for giving such valuable suggestions for improving the rigor of this protocol, which have been added in the revised version. (Page 6, Line 227-233)</p>
<p>Comment 5</p>
<p>the random effects models are appropriate and well through, but the numbers may be small to safely estimate all components, so again the authors may have to compromise. Authors’ response: We sincerely appreciate the reviewer's insightful statistical comments regarding the potential limitations of random-effects models with our sample size. We fully acknowledge that the current data may not provide sufficient power to reliably estimate all variance components in the proposed complex random-effects structure. To address this methodological challenge while maintaining scientific rigor, we will implement a stepwise modeling approach: Initially, we will attempt to fit the pre-specified maximal model incorporating all planned random effects. Should we encounter convergence issues or observe unstable variance estimates (operationally defined as standard errors exceeding the mean estimate), we will systematically simplify the model by first removing random slopes for less critical covariates while preserving random intercepts for key clustering variables like study sites. Throughout this process, we will conduct comprehensive sensitivity analyses to evaluate the impact of model simplifications on both model fit statistics (AIC/BIC) and the stability of fixed-effects estimates, with particular attention to our primary exposure variables. All model adaptations, along with their justifications and validation results, will be thoroughly documented in the supplementary materials to ensure full transparency. (Page 6, Line 241-254)</p>
<p>Reviewer #2: This is a study proposal. The factors under study are very relevant. The study once completed will give good insight into the problem we routinely encounter. A multicenter study will definitely be better</p>
<p>Authors’ response: Thank you for your advice. We will endeavor to conduct a multicenter study once this study is completed and reveals clinically significant insights. We have acknowledged this as a limitation in the Discussion part. (Page 8, Line 327-329)</p>
<p>Reviewer #3:</p>
<p>Comment 1</p>
<p>Clarify the impact of protocol deviations, such as BFR adjustments due to clinical needs, on both ITT and PP analyses by providing more information. It would be helpful for clinicians to clarify this.</p>
<p>Authors’ response: Thank you for your constructive suggestion. When the circuit experiences excessive pressure or triggers pressure alarms at a high BFR, it might be downgraded, which is common in clinical practice. The PP analysis will be performed only for those finished the treatment as planned. Therefore, sessions involving BFR adjustments or changes in anticoagulation modality will be excluded from the PP population to ensure the analysis reflects strict protocol adherence. By contrast, the ITT analysis will include all randomized patients as assigned, regardless of any deviations. We acknowledge that in real-world clinical settings, deviations such as initiating anticoagulation or modifying the BFR during a single CRRT session may occur, typically in response to circuit pressure alarms or clotting risk. Theoretically, whatever anticoagulation modality shifts from anticoagulation-free will aid the prolongation of circuit lifespan. Of note, as the anticoagulant use, the BFR might also be changed (such as when switch to regional citrate anticoagulation). However, such events are expected to occur at a similar rate across the randomized groups. Thank you again for the suggestion, we have enriched discussion part in the revised manuscript. (Page 8, Line 319-323)</p>
<p>Comment 2</p>
<p>Despite the thorough statistical approach, certain terminology (such as use of Poisson instead of negative binomial models) may require a succinct explanation for those unfamiliar with count data and overdispersion.</p>
<p>Authors’ response: Appreciate for your careful review. Poisson regression will be used to model the count data for coagulation frequency, assuming that the mean and variance are equal. If the variance substantially exceeds the mean, a phenomenon known as overdispersion, negative binomial regression may be considered, since it allows for greater flexibility by incorporating a dispersion parameter. (Page 6, Line 255-259)</p>
<p>Comment 3</p>
<p>Despite being written in the usual English language, minor modifications could enhance readability (for instance, “staying patent for 24 hours” could be modified to “maintaining it for at least 24 hours”). Overall, this protocol is technically sound and will provide good data that can inform clinical practice.</p>
<p>Authors’ response: Thanks for your kind suggestions on language, we have modified the corresponding expression to “maintaining it for at least 24 hours” as you suggested. We also thoroughly checked the whole manuscript and made some corrections. (Page 2, Line 54)</p>
<p>Reviewer #4: A randomized controlled trial (RCT) protocol on effects of different blood flow rates on filter life and circuit patency in non-anticoagulation CRRT. this RCT protocol is written in detail and supplementary information file and SPIRIT checklist is complete. I think this protocol satisfies PLOS One publication criteria and is suitable for publication.</p>
<p>Comment 1</p>
<p>I recommend that authors include more information about patients’ safety in the manuscript as they have included in the SI file of trial study protocol. As per PLOS One Submission Guidelines “the name of the registry and the trial or study registration number must be included in the Abstract”.</p>
<p>Authors’ response: Thanks for your advice. Throughout the trial, trained clinical staff will closely monitor adverse events, including hypotension, arrhythmias, bleeding, and other potential complications. if one group exhibits a significantly higher incidence of serious adverse events related to treatment (non-anticoagulation CRRT or BFR setting), such as hypotension, malignant arrhythmia, or death, compared to the other two groups, or if the incidence exceeds predefined safety thresholds, termination of the intervention for that group will be considered immediately. Additionally, an independent Data Safety Monitoring Committee (DSMC) will regularly review trial data to ensure patient safety. Therefore, comprehensive safety monitoring mechanisms have been implemented to effectively protect patient safety throughout the study. We have registered the study protocol at <a href="https://www.chictr.org.cn" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.chictr.org.cn</a> (ChiCTR2400087819) to guarantee it was standardized for patients’ safety and have added it in the Abstract. (Page 1, Line 42; Page 3, Line 104-111)</p>
<p>Comment 2</p>
<p>Moreover, the authors have not described where all data underlying the findings will be made available when the study is complete.</p>
<p>Authors’ response: We thank the reviewer for your careful review. We have now included a Data Availability Statement in the revised manuscript to clarify our plan for data sharing. Specifically, we state that all relevant data from this study will be made available on reasonable request to the corresponding author upon study completion. This addition ensures compliance with PLOS ONE's data availability policy. (Page 9, Line 349-350)</p>
<p>Reviewer #5: In their study protocol titled “Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: protocol for a three-arm, single-blind randomized controlled trial (the FlowCRRT Study),” Liu et al. present an important and timely research question. However, I recommend the following revisions to further strengthen the manuscript.</p>
<p>Comment 1</p>
<p>Page 8, Introduction Section: The introduction fails to clearly explain the reasoning behind the chosen blood flow rate (BFR) thresholds of 150, 200, and 250 mL/min. As a result, readers may struggle to grasp their clinical significance or the supporting evidence. Including a brief justification based on guidelines or common practice would strengthen the study’s foundation.</p>
<p>Authors’ response: Thank you for your constructive suggestions. The Kidney Disease Improving Global Outcomes (KDIGO) consensus guidelines outlined 150-250 mL/min is typically prescribed for CRRT modes such as CVVH and CVVHDF but make no recommendations for practice based on evidence. Recent studies also suggested that very high BFRs (e.g., &gt;250 mL/min) may actually shorten circuit life, possibly due to increased circuit pressure. An RCT comparing BFRs of 150 and 250 mL/min in CRRT found no significant difference in circuit clotting risk. In our center, 200mL/min is the most common BFR setting for anticoagulation-free CRRT. Therefore, based on KDIGO guideline, previous studies, and clinical practice, we established the three BFR levels of 150, 200, and 250 mL/min in this trial. We have provided the supporting evidence on the reason of BFR levels setting in the revised manuscript. (Page 2-3, Line 73-91)</p>
<p>Comment 2</p>
<p>Page 8, Introduction Section: The authors mention conflicting evidence regarding optimal blood flow rates, with some studies recommending BFR &gt;200 mL/min and others suggesting lower rates may improve circuit patency. However, this important issue is not sufficiently discussed. The introduction would benefit from a clearer synthesis of these differing viewpoints and a more explicit acknowledgment of the ongoing debate in the literature. Highlighting this discrepancy would better justify the need for the current study.</p>
<p>Authors’ response: We appreciate the reviewer’s thoughtful and important observation.</p>
<p>Some studies recommend BFR &gt;200 mL/min, however, others pointed out that extremely high BFR (over 250mL/min) might increase the circuit pressure and affect circuit patency. Therefore, “controllable” high BFR might benefit both circuit lifespan and pressure better. Moreover, the KDIGO guidelines suggest that BFRs between 150–250 mL/min are typically prescribed for CRRT modalities such as CVVH and CVVHDF, but offer no evidence-based recommendations for optimal values. Given the relatively low quality, substantial heterogeneity, and controversial findings among previous studies, there is insufficient evidence to draw a solid conclusion on optimal BFR in non-anticoagulation CRRT. Moreover, while clinicians often choose among standard BFR settings (150, 200, or 250 mL/min), no study to date has systematically compared circuit lifespan across these three levels in non-anticoagulated CRRT. Therefore, in this parallel-group, single-blind, three-arm RCT, we aimed to compare the impacts of different BFRs on circuit life and other secondary outcomes in patients receiving non-anticoagulation CRRT. In the revised manuscript, we have highlighted this discrepancy to better justify the need for the current study. (Page 2-3, Line 73-91)</p>
<p>Comment 3</p>
<p>Page 9, Study design: The authors should clearly specify how participants will be blinded to treatment assignment in the study design section. While they mention that allocation concealment will be maintained, the exact method of blinding is not described and should be explicitly stated to ensure transparency and reproducibility.</p>
<p>Authors’ response: Thank you for your valuable comment. To ensure proper blinding in our study, the following measures will be implemented: (1) Allocation Concealment: The CRRT machines and settings will be managed exclusively by the trained CRRT staff, who will not disclose blood flow rate (BFR) assignments to patients or their families. (2) Visual Blinding: The BFR setting on the CRRT machine screen will be obscured or made non-interpretable to patients to prevent inadvertent unblinding. We appreciate your suggestion and have updated the manuscript to explicitly clarify these blinding procedures to enhance transparency and reproducibility. (Page 3, Line 121-125)</p>
<p>Comment 4</p>
<p>Page 9, Study objectives: The authors should avoid vague phrasing and explicitly list the specific secondary outcomes that will be evaluated. Terms like "patient clinical outcomes" and "hemodynamic parameter changes" are too broad, clearly defining which parameters will be assessed is important for the authors to communicate the outcomes effectively.</p>
<p>Authors’ response: We appreciate your thoughtful suggestion for improving the explicitness and rigor of the protocol. We clearly changed “patient clinical outcomes” as patients’ in-hospital mortality, hospital and ICU duration, and invasive mechanical ventilation and dialysis-dependency rate. Blood pressure changes and bleeding occurrence will be recorded during CRRT. We have renewed the information in the S</p>
<section class="sm xbox font-sm" id="pone.0330845.s005"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response letter.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373228/bin/pone.0330845.s005.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330845.s005.docx</a><sup> (36.6KB, docx) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0330845.r003"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0330845.r003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330845.r003</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 1</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaewput%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Wisit Kaewput</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Wisit Kaewput</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaewput%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wisit Kaewput</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.e" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.e" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.e" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Wisit Kaewput</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.e" class="d-panel p" style="display: none">
<div>© 2025 Wisit Kaewput</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>7 Aug 2025</em>
</p>
<p>Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: protocol for a three-arm, single-blind randomized controlled trial (the Flow-CRRT Study)</p>
<p>PONE-D-25-01201R1</p>
<p>Dear Dr. Zhao,</p>
<p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
<p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
<p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Editorial Manager®</a>  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact <a href="https://plos.my.site.com/s/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">billing support</a> .</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>Kind regards,</p>
<p>Wisit Kaewput, MD</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Additional Editor Comments (optional):</p>
<p>Accept as is.</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?</p>
<p>The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?</p>
<p>The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?</p>
<p>Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>4. Have the authors described where all data underlying the findings will be made available when the study is complete?</p>
<p>The <a href="https://journals.plos.org/plosone/s/materials-and-software-sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
<p>Reviewer #1: Yes</p>
<p>**********</p>
<p>6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.</p>
<p>You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.</p>
<p>(Please upload your review as an attachment if it exceeds 20,000 characters)</p>
<p>Reviewer #1: I am satisfied with the authors' responses and resulting changes to the paper. I have no further comments to make.</p>
<p>**********</p>
<p>7. PLOS authors have the option to publish the peer review history of their article (<a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a> .</p>
<p>Reviewer #1: No</p>
<p>**********</p></section></article><article class="sub-article" id="pone.0330845.r004"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0330845.r004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330845.r004</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Acceptance letter</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaewput%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Wisit Kaewput</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Wisit Kaewput</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaewput%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wisit Kaewput</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.f" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.f" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.f" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Wisit Kaewput</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.f" class="d-panel p" style="display: none">
<div>© 2025 Wisit Kaewput</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>PONE-D-25-01201R1</p>
<p>PLOS ONE</p>
<p>Dear Dr. Zhao,</p>
<p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p>
<p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p>
<p>* All references, tables, and figures are properly cited</p>
<p>* All relevant supporting information is included in the manuscript submission,</p>
<p>* There are no issues that prevent the paper from being properly typeset</p>
<p>You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.</p>
<p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at <a href="https://explore.plos.org/phishing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://explore.plos.org/phishing</a>.</p>
<p>If we can help with anything else, please email us at customercare@plos.org.</p>
<p>Thank you for submitting your work to PLOS ONE and supporting open access.</p>
<p>Kind regards,</p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Dr. Wisit Kaewput</p>
<p>Academic Editor</p>
<p>PLOS ONE</p></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 File. SPIRI checklist.</span><p>(DOC)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373228/bin/pone.0330845.s001.doc" data-ga-action="click_feat_suppl" class="usa-link">pone.0330845.s001.doc</a><sup> (121KB, doc) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S2 File. Study protocol in Chinese.</span><p>(DOC)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373228/bin/pone.0330845.s002.doc" data-ga-action="click_feat_suppl" class="usa-link">pone.0330845.s002.doc</a><sup> (147KB, doc) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>S3 File. Study protocol in English.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373228/bin/pone.0330845.s003.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330845.s003.docx</a><sup> (35KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Response letter.docx</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12373228/bin/pone.0330845.s005.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330845.s005.docx</a><sup> (36.6KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0330845"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0330845.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (410.9 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12373228/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12373228/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373228%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373228/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12373228/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12373228/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40845006/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12373228/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40845006/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12373228/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12373228/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="A8xq4pbpuAQBc0ZmNao3FcIXNM8rOA4Bjt26E9k7UqGvM0ILJ95LjhPVmgSMfYzI">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
